Tobias Welte

78.4k total citations · 6 hit papers
957 papers, 35.3k citations indexed

About

Tobias Welte is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Tobias Welte has authored 957 papers receiving a total of 35.3k indexed citations (citations by other indexed papers that have themselves been cited), including 467 papers in Pulmonary and Respiratory Medicine, 308 papers in Epidemiology and 165 papers in Surgery. Recurrent topics in Tobias Welte's work include Pneumonia and Respiratory Infections (163 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (158 papers) and Transplantation: Methods and Outcomes (124 papers). Tobias Welte is often cited by papers focused on Pneumonia and Respiratory Infections (163 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (158 papers) and Transplantation: Methods and Outcomes (124 papers). Tobias Welte collaborates with scholars based in Germany, United States and United Kingdom. Tobias Welte's co-authors include Santiago Ewig, Axel Haverich, Marius M. Hoeper, Jens Gottlieb, Danny Jonigk, Antoni Torres, Thomas Köhnlein, Norbert Suttorp, Florian Laenger and Frank Bühling and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Tobias Welte

892 papers receiving 34.3k citations

Hit Papers

Pulmonary Vascular Endoth... 2007 2026 2013 2019 2020 2007 2017 2010 2014 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
    2020 3.6k citations Maximilian Ackermann, Stijn E. Verleden et al. profile →
  2. Weaning from mechanical ventilation
    2007 1.2k citations Tobias Welte et al. European Respiratory Journal profile →
  3. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
    2017 802 citations Antoní Torres, Santiago Ewig et al. European Respiratory Journal profile →
  4. Clinical and economic burden of community-acquired pneumonia among adults in Europe
    2010 760 citations Tobias Welte et al. profile →
  5. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial
    2014 461 citations Thomas Köhnlein, Tobias Welte et al. profile →
  6. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
    2020 459 citations Tobias Welte et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Welte Germany 89 13.5k 10.3k 5.7k 4.9k 4.3k 957 35.3k
Djillali Annane France 80 8.7k 0.6× 20.6k 2.0× 2.9k 0.5× 9.8k 2.0× 6.7k 1.5× 405 42.4k
Daniel F. McAuley United Kingdom 65 9.5k 0.7× 4.8k 0.5× 5.9k 1.0× 4.8k 1.0× 3.1k 0.7× 371 24.6k
Marcel Levi Netherlands 94 4.9k 0.4× 9.3k 0.9× 6.3k 1.1× 6.4k 1.3× 6.6k 1.5× 526 38.8k
Arthur S. Slutsky Canada 104 32.3k 2.4× 7.4k 0.7× 6.7k 1.2× 13.5k 2.8× 7.0k 1.6× 478 55.2k
Gordon D. Rubenfeld United States 76 14.4k 1.1× 20.0k 1.9× 2.3k 0.4× 11.5k 2.4× 6.4k 1.5× 253 46.3k
Lorraine B. Ware United States 81 17.2k 1.3× 7.9k 0.8× 1.5k 0.3× 5.4k 1.1× 4.3k 1.0× 360 31.0k
Antonio Anzueto United States 61 20.6k 1.5× 12.3k 1.2× 2.4k 0.4× 4.9k 1.0× 1.7k 0.4× 297 34.8k
Mervyn Singer United Kingdom 79 6.5k 0.5× 22.9k 2.2× 2.8k 0.5× 10.1k 2.1× 10.2k 2.4× 462 45.6k
Claudio Ronco Italy 96 9.2k 0.7× 12.2k 1.2× 2.8k 0.5× 9.7k 2.0× 14.7k 3.4× 1.4k 64.4k
Greg S. Martin United States 81 5.5k 0.4× 19.4k 1.9× 2.9k 0.5× 7.7k 1.6× 6.0k 1.4× 377 45.1k

Countries citing papers authored by Tobias Welte

Since Specialization
Citations

This map shows the geographic impact of Tobias Welte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Welte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Welte more than expected).

Fields of papers citing papers by Tobias Welte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Welte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Welte. The network helps show where Tobias Welte may publish in the future.

Co-authorship network of co-authors of Tobias Welte

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Welte. A scholar is included among the top collaborators of Tobias Welte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Welte. Tobias Welte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dietrich, Jana, Alice J. Kang, Stijn E. Verleden, et al.. (2025). The role of vascularity and the fibrovascular interface in interstitial lung diseases. European Respiratory Review. 34(175). 240080–240080.
2.
Suhling, Hendrik, Jan Fuge, Nora Drick, et al.. (2024). Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy. BMC Pulmonary Medicine. 24(1). 149–149. 4 indexed citations
3.
Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2024). Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. Clinical Infectious Diseases. 80(1). 63–71. 5 indexed citations
4.
Kahnert, Kathrin, Rudolf A. Jörres, Hans‐Ulrich Kauczor, et al.. (2023). Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic Advances in Respiratory Disease. 17. 2673727991–2673727991. 13 indexed citations
5.
Kamp, Jan C., Carlos Fernández Moro, Jan Fuge, et al.. (2023). Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses. International Journal of Molecular Sciences. 24(3). 2485–2485. 4 indexed citations
6.
Stahl, Klaus, Yulia Kiyan, Benjamin Seeliger, et al.. (2021). Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock. Intensive Care Medicine Experimental. 9(1). 57–57. 22 indexed citations
7.
Drick, Nora, Katrin Milger, Benjamin Seeliger, et al.. (2020). <p>Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma</p>. Journal of Asthma and Allergy. Volume 13. 605–614. 34 indexed citations
8.
Janciauskiene, Sabina & Tobias Welte. (2016). Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments. Annals of the American Thoracic Society. 13(Supplement_4). S280–S288. 87 indexed citations
9.
Houben‐Wilke, Sarah, Rudolf A. Jörres, Robert Bals, et al.. (2016). Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences–Comorbidities Network Study. American Journal of Respiratory and Critical Care Medicine. 195(2). 189–197. 69 indexed citations
10.
Fritzsching, Benedikt, Zhe Zhou-Suckow, Joanna Trojanek, et al.. (2015). Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 191(8). 902–913. 81 indexed citations
11.
Fuehner, Thomas, C. Kuehn, I. Tudorache, et al.. (2012). Extracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 185(7). 763–768. 42 indexed citations
12.
Wilson, Robert C., Tobias Welte, Eva Polverino, et al.. (2011). Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. European Respiratory Journal. 38(Suppl 55). 1929–1929. 5 indexed citations
13.
Alder, Jeff, Robert C. Wilson, Tobias Welte, et al.. (2011). Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. European Respiratory Journal. 38(Suppl 55). 1930–1930. 4 indexed citations
14.
Esperatti, Mariano, Miquel Ferrer, Adamantia Liapikou, et al.. (2010). Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients. American Journal of Respiratory and Critical Care Medicine. 182(12). 1533–1539. 138 indexed citations
15.
Krüger, Stefan, Santiago Ewig, Sven Giersdorf, et al.. (2010). Cardiovascular and Inflammatory Biomarkers to Predict Short- and Long-Term Survival in Community-acquired Pneumonia: Results from the German Competence Network, CAPNETZ. American Journal of Respiratory and Critical Care Medicine. 182(11). 1426–1434. 163 indexed citations
16.
Welte, Tobias, Marc Miravitlles, Paul Hernandez, et al.. (2009). Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 180(8). 741–750. 303 indexed citations
17.
Maus, Ulrich A., Christine Winter, Mrigank Srivastava, et al.. (2007). Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection. American Journal of Respiratory and Critical Care Medicine. 175(9). 958–966. 65 indexed citations
18.
Wulffen, Werner von, Susanne Herold, Leigh M. Marsh, et al.. (2007). Lung Dendritic Cells Elicited by Fms-like Tyrosin 3-Kinase Ligand Amplify the Lung Inflammatory Response to Lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine. 176(9). 892–901. 28 indexed citations
19.
Sokolova, Elena, et al.. (2004). Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(5). L793–L802. 33 indexed citations
20.
Wiede, Antje, et al.. (1999). Localization of TFF3, a New Mucus-associated Peptide of the Human Respiratory Tract. American Journal of Respiratory and Critical Care Medicine. 159(4). 1330–1335. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Djillali Annane Breakdown of academic impact, for papers by Daniel F. McAuley Breakdown of academic impact, for papers by Marcel Levi Breakdown of academic impact, for papers by Arthur S. Slutsky Breakdown of academic impact, for papers by Gordon D. Rubenfeld Breakdown of academic impact, for papers by Lorraine B. Ware Breakdown of academic impact, for papers by Antonio Anzueto Breakdown of academic impact, for papers by Mervyn Singer Breakdown of academic impact, for papers by Claudio Ronco Breakdown of academic impact, for papers by Greg S. Martin
Rankless by CCL
2026